Tanoli Z, Fernández-Torras A, Özcan UO, Kushnir A, Nader KM, Gadiya Y, Fiorenza L, Ianevski A, Vähä-Koskela M, Miihkinen M, Seemab U, Leinonen H, Seashore-Ludlow B, Tampere M, Kalman A, Ballante F, Benfenati E, Saunders G, Potdar S, Gómez García I, García-Serna R, Talarico C, Beccari AR, Schaal W, Polo A et al. (2025)
Computational drug repurposing: approaches, evaluation of in silico resources and case studies
Nat Rev Drug Discov (in press)
DOI 10.1038/s41573-025-01164-x, PubMed 40102635

Yin Y, Xu H, He L, Brown JR, Mato AR, Aittokallio T, Skånland SS (2025)
Protein profiles predict treatment responses to the PI3K inhibitor umbralisib in patients with chronic lymphocytic leukemia
Clin Cancer Res (in press)
DOI 10.1158/1078-0432.CCR-24-2911, PubMed 40085050

Huusari R, Wang T, Szedmak S, Dias D, Aittokallio T, Rousu J (2025)
Scaling up drug combination surface prediction
Brief Bioinform, 26 (2)
DOI 10.1093/bib/bbaf099, PubMed 40079263